Cargando…

N-terminal pro-B-type natriuretic peptide and microsize myocardial infarction risk in the reasons for geographic and racial differences in stroke study

BACKGROUND: N-terminal pro B-type peptide (NT-proBNP) has been associated with risk of myocardial infarction (MI), but less is known about the relationship between NT-proBNP and very small non ST-elevation MI, also known as microsize MI. These events are now routinely detectable with modern troponin...

Descripción completa

Detalles Bibliográficos
Autores principales: Sterling, Madeline R., Durant, Raegan W., Bryan, Joanna, Levitan, Emily B., Brown, Todd M., Khodneva, Yulia, Glasser, Stephen P., Richman, Joshua S., Howard, George, Cushman, Mary, Safford, Monika M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5902876/
https://www.ncbi.nlm.nih.gov/pubmed/29661151
http://dx.doi.org/10.1186/s12872-018-0806-4
_version_ 1783314832168058880
author Sterling, Madeline R.
Durant, Raegan W.
Bryan, Joanna
Levitan, Emily B.
Brown, Todd M.
Khodneva, Yulia
Glasser, Stephen P.
Richman, Joshua S.
Howard, George
Cushman, Mary
Safford, Monika M.
author_facet Sterling, Madeline R.
Durant, Raegan W.
Bryan, Joanna
Levitan, Emily B.
Brown, Todd M.
Khodneva, Yulia
Glasser, Stephen P.
Richman, Joshua S.
Howard, George
Cushman, Mary
Safford, Monika M.
author_sort Sterling, Madeline R.
collection PubMed
description BACKGROUND: N-terminal pro B-type peptide (NT-proBNP) has been associated with risk of myocardial infarction (MI), but less is known about the relationship between NT-proBNP and very small non ST-elevation MI, also known as microsize MI. These events are now routinely detectable with modern troponin assays and are emerging as a large proportion of all MI. Here, we sought to compare the association of NT-proBNP with risk of incident typical MI and microsize MI in the REasons for Geographic and Racial Differences in Stroke (REGARDS) Study. METHODS: The REGARDS Study is a national cohort of 30,239 US community-dwelling black and white adults aged ≥ 45 years recruited from 2003 to 2007. Expert-adjudicated outcomes included incident typical MI (definite/probable MI with peak troponin ≥ 0.5 μg/L), incident microsize MI (definite/probable MI with peak troponin < 0.5 μg/L), and incident fatal CHD. Using a case-cohort design, we estimated the hazard ratio of the outcomes as a function of baseline NT-proBNP. Competing risk analyses tested whether the associations of NT-proBNP differed between the risk of incident microsize MI and incident typical MI as well as if the association of NT-proBNP differed between incident non-fatal microsize MI and incident non-fatal typical MI, while accounting for incident fatal coronary heart disease (CHD) as well as heart failure (HF). RESULTS: Over a median of 5 years of follow-up, there were 315 typical MI, 139 microsize MI, and 195 incident fatal CHD. NT-proBNP was independently and strongly associated with all CHD endpoints, with significantly greater risk observed for incident microsize MI, even after removing individuals with suspected HF prior to or coincident with their incident CHD event. CONCLUSION: NT-proBNP is associated with all MIs, but is a more powerful risk factor for microsize than typical MI. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12872-018-0806-4) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5902876
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-59028762018-04-23 N-terminal pro-B-type natriuretic peptide and microsize myocardial infarction risk in the reasons for geographic and racial differences in stroke study Sterling, Madeline R. Durant, Raegan W. Bryan, Joanna Levitan, Emily B. Brown, Todd M. Khodneva, Yulia Glasser, Stephen P. Richman, Joshua S. Howard, George Cushman, Mary Safford, Monika M. BMC Cardiovasc Disord Research Article BACKGROUND: N-terminal pro B-type peptide (NT-proBNP) has been associated with risk of myocardial infarction (MI), but less is known about the relationship between NT-proBNP and very small non ST-elevation MI, also known as microsize MI. These events are now routinely detectable with modern troponin assays and are emerging as a large proportion of all MI. Here, we sought to compare the association of NT-proBNP with risk of incident typical MI and microsize MI in the REasons for Geographic and Racial Differences in Stroke (REGARDS) Study. METHODS: The REGARDS Study is a national cohort of 30,239 US community-dwelling black and white adults aged ≥ 45 years recruited from 2003 to 2007. Expert-adjudicated outcomes included incident typical MI (definite/probable MI with peak troponin ≥ 0.5 μg/L), incident microsize MI (definite/probable MI with peak troponin < 0.5 μg/L), and incident fatal CHD. Using a case-cohort design, we estimated the hazard ratio of the outcomes as a function of baseline NT-proBNP. Competing risk analyses tested whether the associations of NT-proBNP differed between the risk of incident microsize MI and incident typical MI as well as if the association of NT-proBNP differed between incident non-fatal microsize MI and incident non-fatal typical MI, while accounting for incident fatal coronary heart disease (CHD) as well as heart failure (HF). RESULTS: Over a median of 5 years of follow-up, there were 315 typical MI, 139 microsize MI, and 195 incident fatal CHD. NT-proBNP was independently and strongly associated with all CHD endpoints, with significantly greater risk observed for incident microsize MI, even after removing individuals with suspected HF prior to or coincident with their incident CHD event. CONCLUSION: NT-proBNP is associated with all MIs, but is a more powerful risk factor for microsize than typical MI. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12872-018-0806-4) contains supplementary material, which is available to authorized users. BioMed Central 2018-04-16 /pmc/articles/PMC5902876/ /pubmed/29661151 http://dx.doi.org/10.1186/s12872-018-0806-4 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Sterling, Madeline R.
Durant, Raegan W.
Bryan, Joanna
Levitan, Emily B.
Brown, Todd M.
Khodneva, Yulia
Glasser, Stephen P.
Richman, Joshua S.
Howard, George
Cushman, Mary
Safford, Monika M.
N-terminal pro-B-type natriuretic peptide and microsize myocardial infarction risk in the reasons for geographic and racial differences in stroke study
title N-terminal pro-B-type natriuretic peptide and microsize myocardial infarction risk in the reasons for geographic and racial differences in stroke study
title_full N-terminal pro-B-type natriuretic peptide and microsize myocardial infarction risk in the reasons for geographic and racial differences in stroke study
title_fullStr N-terminal pro-B-type natriuretic peptide and microsize myocardial infarction risk in the reasons for geographic and racial differences in stroke study
title_full_unstemmed N-terminal pro-B-type natriuretic peptide and microsize myocardial infarction risk in the reasons for geographic and racial differences in stroke study
title_short N-terminal pro-B-type natriuretic peptide and microsize myocardial infarction risk in the reasons for geographic and racial differences in stroke study
title_sort n-terminal pro-b-type natriuretic peptide and microsize myocardial infarction risk in the reasons for geographic and racial differences in stroke study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5902876/
https://www.ncbi.nlm.nih.gov/pubmed/29661151
http://dx.doi.org/10.1186/s12872-018-0806-4
work_keys_str_mv AT sterlingmadeliner nterminalprobtypenatriureticpeptideandmicrosizemyocardialinfarctionriskinthereasonsforgeographicandracialdifferencesinstrokestudy
AT durantraeganw nterminalprobtypenatriureticpeptideandmicrosizemyocardialinfarctionriskinthereasonsforgeographicandracialdifferencesinstrokestudy
AT bryanjoanna nterminalprobtypenatriureticpeptideandmicrosizemyocardialinfarctionriskinthereasonsforgeographicandracialdifferencesinstrokestudy
AT levitanemilyb nterminalprobtypenatriureticpeptideandmicrosizemyocardialinfarctionriskinthereasonsforgeographicandracialdifferencesinstrokestudy
AT browntoddm nterminalprobtypenatriureticpeptideandmicrosizemyocardialinfarctionriskinthereasonsforgeographicandracialdifferencesinstrokestudy
AT khodnevayulia nterminalprobtypenatriureticpeptideandmicrosizemyocardialinfarctionriskinthereasonsforgeographicandracialdifferencesinstrokestudy
AT glasserstephenp nterminalprobtypenatriureticpeptideandmicrosizemyocardialinfarctionriskinthereasonsforgeographicandracialdifferencesinstrokestudy
AT richmanjoshuas nterminalprobtypenatriureticpeptideandmicrosizemyocardialinfarctionriskinthereasonsforgeographicandracialdifferencesinstrokestudy
AT howardgeorge nterminalprobtypenatriureticpeptideandmicrosizemyocardialinfarctionriskinthereasonsforgeographicandracialdifferencesinstrokestudy
AT cushmanmary nterminalprobtypenatriureticpeptideandmicrosizemyocardialinfarctionriskinthereasonsforgeographicandracialdifferencesinstrokestudy
AT saffordmonikam nterminalprobtypenatriureticpeptideandmicrosizemyocardialinfarctionriskinthereasonsforgeographicandracialdifferencesinstrokestudy